HOST-TUMOR-DRUG RELATIONSHIPS IN EXPERIMENTAL CHEMOTHERAPY SYSTEMS WITH ALLOGENEIC AND XENOGENEIC HOST-TUMOR COMBINATIONS.
D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001377:Azaserine; D002294:Carcinoma, Squamous Cell; D002614:Chelating Agents; D003348:Cortisone; D007930:Leucine; D015122:Mercaptopurine; D051379:Mice; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental; D051381:Rats; D012106:Research; D012510:Sarcoma 180; D013307:Streptomycin; D013866:Thioguanine; D014180:Transplantation
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002614:Chelating Agents; D001377:Azaserine; D015122:Mercaptopurine; D013866:Thioguanine; D007930:Leucine; D003348:Cortisone; D013307:Streptomycin
ANTINEOPLASTIC AGENTS; AZASERINE; CARCINOMA, EPIDERMOID; CHELATING AGENTS; CORTISONE; EXPERIMENTAL LAB STUDY; LEUCINE; MERCAPTOPURINE; MICE; NEOPLASM IMMUNOLOGY; NEOPLASMS, EXPERIMENTAL; RATS; SARCOMA 180, CROCKER; STREPTOMYCIN; THIOGUANINE; TRANSPLANTATION